anmelden
FTSE All-Share
5.805,22
PKT
-9,88
PKT
-0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.02.12 | Diageo halten | Independent Research GmbH | |
| 10.02.12 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 10.02.12 | Diageo buy | Goldman Sachs Group Inc. | |
| 10.02.12 | Vodafone Group buy | Nomura | |
| 10.02.12 | Diageo neutral | Nomura | |
| 10.02.12 | Rio Tinto outperform | RBC Capital Markets | |
| 10.02.12 | Diageo buy | Société Générale Group S.A. (SG) | |
| 10.02.12 | Glencore buy | Banc of America Securities-Merrill Lynch | |
| 09.02.12 | Vodafone Group buy | ING | |
| 09.02.12 | GSK neutral | J.P. Morgan Cazenove | |
| 09.02.12 | BP outperform | Macquarie Research | |
| 09.02.12 | HSBC buy | Goldman Sachs Group Inc. | |
| 09.02.12 | Glencore overweight | HSBC | |
| 09.02.12 | Glencore neutral | Sarasin Research | |
| 09.02.12 | Anglo American outperform | RBC Capital Markets | |
| 09.02.12 | Tullow Oil kaufen | Focus Money | |
| 09.02.12 | BP neutral | Goldman Sachs Group Inc. | |
| 09.02.12 | BP outperform | RBC Capital Markets | |
| 09.02.12 | BP buy | Deutsche Bank AG | |
| 09.02.12 | GSK neutral | Credit Suisse Group | |
| 08.02.12 | GSK buy | UBS AG | |
| 08.02.12 | GSK halten | Independent Research GmbH | |
| 08.02.12 | Barclays buy | Citigroup Corp. | |
| 08.02.12 | Barclays sell | Goldman Sachs Group Inc. | |
| 08.02.12 | Rio Tinto buy | Deutsche Bank AG | |
| 08.02.12 | GSK verkaufen | Hamburger Sparkasse AG (Haspa) | |
| 08.02.12 | GSK buy | UBS AG | |
| 08.02.12 | BP buy | UBS AG | |
| 08.02.12 | Glencore buy | UBS AG | |
| 08.02.12 | GSK equal-weight | Morgan Stanley | |
| 08.02.12 | Diageo hold | ING | |
| 08.02.12 | BP halten | Independent Research GmbH | |
| 08.02.12 | Vodafone Group overweight | J.P. Morgan Cazenove | |
| 08.02.12 | BP neutral | Nomura | |
| 08.02.12 | Shell (ex Royal Dutch Shell) kaufen | Hamburger Sparkasse AG (Haspa) | |
| 08.02.12 | GSK neutral | Sarasin Research | |
| 08.02.12 | BP hold | Société Générale Group S.A. (SG) | |
| 08.02.12 | Shell (ex Royal Dutch Shell) neutral | HSBC | |
| 08.02.12 | Glencore outperform | Credit Suisse Group | |
| 07.02.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch |
